CORRECTION TO BASIC AND CLINICAL RESEARCH ON RETT SYNDROME AND MECP2 
PROGRAM ANNOUNCEMENT (PA-03-097)

RELEASE DATE:  April 22, 2003
 
NOTICE:  NOT-NS-03-014

National Institute of Neurological Disorders and Stroke (NINDS)
 (http://www.ninds.nih.gov)
National Institute of Child Health and Human Development (NICHD)
 (http://www.nichd.nih.gov)  

This is a change to the Program Announcement "Basic and Clinical
Research on Rett Syndrome and MeCP2".  In the SUBMITTING AN APPLICATION 
section, the following text has been inserted after the second 
paragraph:

SUPPLEMENTAL INSTRUCTIONS:  All instructions for the PHS 398 (rev. 
5/2001) must be followed, with these exceptions:

o   Research Plan

For R21 applications only, items a – d of the Research Plan (Specific 
Aims, Background and Significance, Preliminary Studies, and Research 
Design and Methods) may not exceed a total of 15 pages.  No preliminary 
data is required for R21 proposals, but may be included if it is 
available.  Please note that a Progress Report is not needed for R21 
awards; competing continuation applications for an 
exploratory/developmental grant will not be accepted.

Appendix.  Use the instructions for the appendix detailed in the PHS 
398 except that for R21 applications, no more than 5 manuscripts, 
previously accepted for publication, may be included.

INQUIRIES

Robert Finkelstein, Ph.D.
Neurogenetics Cluster
NINDS
6001 Executive Boulevard, Room 2143
Bethesda, MD 20892-9527
Telephone:  (301) 496-5745
FAX:  (301)  402-1501
Email:  rf45c@nih.gov

Return to Volume Index

Return to NIH Guide Main Index

	Office of Extramural Research (OER)			National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892			Department of Health and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, RealPlayer, Video or Flash files, see Help Downloading Files.